Hsu Sylvia, Papp Kim Alexander, Lebwohl Mark G, Bagel Jerry, Blauvelt Andrew, Duffin Kristina Callis, Crowley Jeffrey, Eichenfield Lawrence F, Feldman Steven R, Fiorentino David F, Gelfand Joel M, Gottlieb Alice B, Jacobsen Carmen, Kalb Robert E, Kavanaugh Arthur, Korman Neil J, Krueger Gerald G, Michelon Melissa A, Morison Warwick, Ritchlin Christopher T, Stein Gold Linda, Stone Stephen P, Strober Bruce E, Van Voorhees Abby S, Weiss Stefan C, Wanat Karolyn, Bebo Bruce F
Department of Dermatology, Baylor College of Medicine, Houston, TX 77030, USA.
Arch Dermatol. 2012 Jan;148(1):95-102. doi: 10.1001/archdermatol.2011.1410.
The Canadian Guidelines for the Management of Plaque Psoriasis were reviewed by the entire National Psoriasis Foundation Medical Board and updated to include newly approved agents such as ustekinumab and to reflect practice patterns in the United States, where the excimer laser is approved for psoriasis treatment. Management of psoriasis in special populations is discussed. In the updated guidelines, we include sections on children, pregnant patients or pregnant partners of patients, nursing mothers, the elderly, patients with hepatitis B or C virus infections, human immunodeficiency virus-infected patients, and patients with malignant neoplasms, as well as sections on tumor necrosis factor blockers, elective surgery, and vaccinations.
加拿大斑块状银屑病管理指南由全国银屑病基金会医学委员会全体成员进行了审查，并进行了更新，纳入了诸如优特克单抗等新批准的药物，并反映了美国的实践模式，在美国准分子激光已获批用于银屑病治疗。文中还讨论了特殊人群中银屑病的管理。在更新后的指南中，我们纳入了关于儿童、孕妇或患者的怀孕伴侣、哺乳期母亲、老年人、乙型或丙型肝炎病毒感染患者、人类免疫缺陷病毒感染患者以及恶性肿瘤患者的章节，还有关于肿瘤坏死因子阻滞剂、择期手术和疫苗接种的章节。
